Viveve Medical Inc EV/EBIT
What is the EV/EBIT of Viveve Medical Inc?
The EV/EBIT of Viveve Medical Inc is N/A
What is the definition of EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT of companies in the Health Care sector on NASDAQ compared to Viveve Medical Inc
What does Viveve Medical Inc do?
viveve provides women low risk, high reward medical procedures that promote personal health and wellness. the company is committed to innovative technological advances and to broad and elucidating education for medical and lay audiences worldwide.
Companies with ev/ebit similar to Viveve Medical Inc
- Digital Landscape has EV/EBIT of N/A
- Immunome has EV/EBIT of N/A
- Royal BAM Groep NV has EV/EBIT of N/A
- CURO Corp has EV/EBIT of N/A
- Adial Pharmaceuticals has EV/EBIT of N/A
- NuZee has EV/EBIT of N/A
- Viveve Medical Inc has EV/EBIT of N/A
- Syros Pharmaceuticals has EV/EBIT of N/A
- Minerva Intelligence has EV/EBIT of N/A
- windeln.de SE has EV/EBIT of N/A
- Smith Micro Software has EV/EBIT of N/A
- Viaan Industries has EV/EBIT of N/A
- Lantern Pharma has EV/EBIT of N/A